关于阿瓦斯汀等药物“超适应症”使用的一些伦理考量。
Some ethical considerations for the "off-label" use of drugs such as Avastin.
作者信息
Wong D, Kyle G
机构信息
St Paul's Eye Unit, Royal Liverpool University Trust Hospital, Liverpool, UK.
出版信息
Br J Ophthalmol. 2006 Oct;90(10):1218-9. doi: 10.1136/bjo.2006.102426.
Abstract
Is off‐label use of drugs legal?
摘要
药物的非标签使用是否合法？
相似文献
1
Some ethical considerations for the "off-label" use of drugs such as Avastin.关于阿瓦斯汀等药物“超适应症”使用的一些伦理考量。
Br J Ophthalmol. 2006 Oct;90(10):1218-9. doi: 10.1136/bjo.2006.102426.
2
Position paper: the need for head-to-head studies comparing Avastin versus Lucentis.立场文件：需要进行阿瓦斯汀与雷珠单抗的直接对比研究。
Surv Ophthalmol. 2009 Nov-Dec;54(6):705-7. doi: 10.1016/j.survophthal.2009.08.002.
3
Avastin versus Lucentis: ethical issues in treatment of age-related macular degeneration.阿瓦斯汀与雷珠单抗：年龄相关性黄斑变性治疗中的伦理问题。
Retina. 2007 Nov-Dec;27(9):1163-5. doi: 10.1097/IAE.0b013e31815e9322.
4
Avastin versus Lucentis: ethical issues.安维汀与雷珠单抗：伦理问题。
Retina. 2008 Jul-Aug;28(7):1024-5; author reply 1025. doi: 10.1097/IAE.0b013e318176de5f.
5
CATT: Into the eye of a tiger.结膜相关淋巴组织：进入虎眼之中。 （注：CATT是结膜相关淋巴组织Conjunctiva-Associated Lymphoid Tissue的缩写，不过按照要求未做额外解释说明）
Br J Ophthalmol. 2011 Jun;95(6):761. doi: 10.1136/bjophthalmol-2011-300406.
6
Treatments for macular degeneration: summarising evidence using network meta-analysis.黄斑变性的治疗：使用网状Meta分析总结证据
Br J Ophthalmol. 2011 Oct;95(10):1476-7. doi: 10.1136/bjophthalmol-2011-300316. Epub 2011 Jun 16.
7
Bevacizumab: a new way of doing business?贝伐单抗：一种新的经营方式？
Eye (Lond). 2006 Sep;20(9):985-7. doi: 10.1038/sj.eye.6702501. Epub 2006 Jul 21.
8
Intravitreal avastin: the low cost alternative to lucentis?玻璃体内注射阿瓦斯汀：雷珠单抗的低成本替代方案？
Am J Ophthalmol. 2006 Jul;142(1):141-3. doi: 10.1016/j.ajo.2006.03.036.
9
Intravitreal VEGF-inhibitors: is Avastin a generic substitute for Lucentis?玻璃体内注射血管内皮生长因子（VEGF）抑制剂：阿瓦斯汀（Avastin）能否作为雷珠单抗（Lucentis）的通用替代品？
Acta Ophthalmol Scand. 2007 Feb;85(1):2-4. doi: 10.1111/j.1600-0420.2006.00869.x.
10
Avastin and new treatments for AMD: where are we?阿瓦斯汀与年龄相关性黄斑变性的新疗法：我们进展到哪一步了？
Retina. 2006 Oct;26(8):853-8. doi: 10.1097/01.iae.0000244722.35073.7c.
引用本文的文献
1
Off-label use of bevacizumab for the treatment of age-related macular degeneration: what is the evidence?贝伐单抗用于治疗年龄相关性黄斑变性的超说明书用药：证据是什么？
Drugs Aging. 2009;26(4):295-320. doi: 10.2165/00002512-200926040-00002.
2
Off-label use of medicines: medical research and medical practice.药品的非标签使用：医学研究与医疗实践。
Indian J Ophthalmol. 2007 Nov-Dec;55(6):411-2. doi: 10.4103/0301-4738.36472.
本文引用的文献
1
Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.玻璃体腔内注射贝伐单抗治疗年龄相关性黄斑变性继发脉络膜新生血管
Retina. 2006 Apr;26(4):383-90. doi: 10.1097/01.iae.0000238561.99283.0e.
2
Intravitreal bevacizumab in a patient with neovascular glaucoma.玻璃体内注射贝伐单抗治疗新生血管性青光眼患者。
Ophthalmic Surg Lasers Imaging. 2006 Mar-Apr;37(2):144-6.
3
Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.玻璃体内注射贝伐单抗（阿瓦斯汀）治疗后视网膜和虹膜新生血管的消退。
Retina. 2006 Mar;26(3):352-4. doi: 10.1097/00006982-200603000-00016.
4
Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study.玻璃体内注射贝伐单抗（阿瓦斯汀）治疗视网膜中央静脉阻塞所致黄斑水肿的短期研究。
Retina. 2006 Mar;26(3):279-84. doi: 10.1097/00006982-200603000-00005.
5
Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage.玻璃体内注射贝伐单抗（阿瓦斯汀）治疗增殖性糖尿病视网膜病变合并玻璃体积血。
Retina. 2006 Mar;26(3):275-8. doi: 10.1097/00006982-200603000-00004.
6
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.玻璃体内注射贝伐单抗（阿瓦斯汀）治疗新生血管性年龄相关性黄斑变性。
Ophthalmology. 2006 Mar;113(3):363-372.e5. doi: 10.1016/j.ophtha.2005.11.019. Epub 2006 Feb 3.
7
Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion.玻璃体内注射贝伐单抗（阿瓦斯汀）治疗视网膜中央静脉阻塞所致黄斑水肿后的光学相干断层扫描结果
Ophthalmic Surg Lasers Imaging. 2005 Jul-Aug;36(4):336-9.
8
Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.玻璃体内注射贝伐单抗（阿瓦斯汀）治疗新生血管性年龄相关性黄斑变性后的光学相干断层扫描结果
Ophthalmic Surg Lasers Imaging. 2005 Jul-Aug;36(4):331-5.
9
Intravitreal bevacizumab for choroidal neovascularization and cystoid macular edema: a cost-effective treatment?玻璃体内注射贝伐单抗治疗脉络膜新生血管和黄斑囊样水肿：一种具有成本效益的治疗方法？
Ophthalmic Surg Lasers Imaging. 2005 Jul-Aug;36(4):270-1.
10
Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2.维替泊芬光动力疗法治疗黄斑中心凹下脉络膜新生血管：荧光素血管造影评估与治疗指南——TAP和VIP报告第2号
Arch Ophthalmol. 2003 Sep;121(9):1253-68. doi: 10.1001/archopht.121.9.1253.
Zotero 插件